This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Musculoskeletal Syndromes (Chronic Fatigue, Gulf War)  • Adverse Effects  • Alert me on articles by topic

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

As Hansen et al¹ noted in their report of outcomes in patients with statin-associated myopathy, their study is limited by retrospective medical chart assessment of patients with symptoms of muscle pain or weakness or the laboratory finding of an elevated creatine kinase level. The frequency of muscle weakness was not based on a routine physical examination. Only 1 in 3 subjects had symptoms of weakness, but the authors could not determine from the medical charts whether subjects were asked about a decline in the ability to walk and climb stairs, to lift items previously raised easily, to arise from a toilet seat or get into and out of a car, and to participate in recreational activities. We have found that many patients who were eventually diagnosed as having a statin-induced myopathy did not report functional declines unless asked about changes in specific daily activities.²

The authors state that objective muscle . . . [Full Text of this Article]

AUTHOR INFORMATION
Bruce H. Dobkin, MD, FRCP

RELATED ARTICLES

Outcomes in 45 Patients With Statin-Associated Myopathy
Karen E. Hansen, Julie P. Hildebrand, Edwin E. Ferguson, and James H. Stein
Arch Intern Med. 2005;165(22):2671-2676.
ABSTRACT | FULL TEXT  

Statin-Associated Myopathy
Paul D. Thompson, Priscilla Clarkson, and Richard H. Karas
JAMA. 2003;289(13):1681-1690.
ABSTRACT | FULL TEXT